Copyright Reports & Markets. All rights reserved.

Global Medical Radioactive Isotopes Market Opportunities and Forecast 2022-2028

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Medical Radioactive Isotopes Market Status and Forecast (2017-2028)
      • 1.3.2 Global Medical Radioactive Isotopes Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Medical Radioactive Isotopes Supply by Company

    • 2.1 Global Medical Radioactive Isotopes Sales Volume by Company
    • 2.2 Global Medical Radioactive Isotopes Sales Value by Company
    • 2.3 Global Medical Radioactive Isotopes Price by Company
    • 2.4 Medical Radioactive Isotopes Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Medical Radioactive Isotopes Market Status by Type

    • 3.1 Medical Radioactive Isotopes Type Introduction
      • 3.1.1 Tc-99m
      • 3.1.2 Cobalt-60
      • 3.1.3 Iodine Radioisotopes
    • 3.2 Global Medical Radioactive Isotopes Market by Type
      • 3.2.1 Global Medical Radioactive Isotopes Sales Volume by Type (2017-2022)
      • 3.2.2 Global Medical Radioactive Isotopes Sales Value by Type (2017-2022)
      • 3.2.3 Global Medical Radioactive Isotopes Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Medical Radioactive Isotopes Market Status by Application

    • 4.1 Medical Radioactive Isotopes Segment by Application
      • 4.1.1 Nuclear Therapy
      • 4.1.2 Equipment Radioactive Source
      • 4.1.3 Diagnosis
      • 4.1.4 Others
    • 4.2 Global Medical Radioactive Isotopes Market by Application
      • 4.2.1 Global Medical Radioactive Isotopes Sales Volume by Application (2017-2022)
      • 4.2.2 Global Medical Radioactive Isotopes Sales Value by Application (2017-2022)
      • 4.2.3 Global Medical Radioactive Isotopes Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Medical Radioactive Isotopes Market Status by Region

    • 5.1 Global Medical Radioactive Isotopes Market by Region
      • 5.1.1 Global Medical Radioactive Isotopes Sales Volume by Region
      • 5.1.2 Global Medical Radioactive Isotopes Sales Value by Region
    • 5.2 North America Medical Radioactive Isotopes Market Status
    • 5.3 Europe Medical Radioactive Isotopes Market Status
    • 5.4 Asia Pacific Medical Radioactive Isotopes Market Status
    • 5.5 Central & South America Medical Radioactive Isotopes Market Status
    • 5.6 Middle East & Africa Medical Radioactive Isotopes Market Status

    6 North America Medical Radioactive Isotopes Market Status

    • 6.1 North America Medical Radioactive Isotopes Market by Country
      • 6.1.1 North America Medical Radioactive Isotopes Sales Volume by Country (2017-2022)
      • 6.1.2 North America Medical Radioactive Isotopes Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Medical Radioactive Isotopes Market Status

    • 7.1 Europe Medical Radioactive Isotopes Market by Country
      • 7.1.1 Europe Medical Radioactive Isotopes Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Medical Radioactive Isotopes Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Medical Radioactive Isotopes Market Status

    • 8.1 Asia Pacific Medical Radioactive Isotopes Market by Country
      • 8.1.1 Asia Pacific Medical Radioactive Isotopes Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Medical Radioactive Isotopes Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Medical Radioactive Isotopes Market Status

    • 9.1 Central & South America Medical Radioactive Isotopes Market by Country
      • 9.1.1 Central & South America Medical Radioactive Isotopes Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Medical Radioactive Isotopes Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Medical Radioactive Isotopes Market Status

    • 10.1 Middle East & Africa Medical Radioactive Isotopes Market by Country
      • 10.1.1 Middle East & Africa Medical Radioactive Isotopes Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Medical Radioactive Isotopes Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Medical Radioactive Isotopes Manufacturing Cost Analysis
    • 11.5 Medical Radioactive Isotopes Sales Channel and Distributors Analysis
      • 11.5.1 Medical Radioactive Isotopes Sales Channel
      • 11.5.2 Medical Radioactive Isotopes Distributors
    • 11.6 Medical Radioactive Isotopes Downstream Major Buyers

    12 Global Medical Radioactive Isotopes Market Forecast by Type and by Application

    • 12.1 Global Medical Radioactive Isotopes Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Medical Radioactive Isotopes Forecast by Type
      • 12.2.1 Global Medical Radioactive Isotopes Sales Volume Forecast by Type
      • 12.2.2 Global Medical Radioactive Isotopes Sales Value Forecast by Type
      • 12.2.3 Global Medical Radioactive Isotopes Price Forecast by Type
    • 12.3 Global Medical Radioactive Isotopes Forecast by Application
      • 12.3.1 Global Medical Radioactive Isotopes Sales Volume Forecast by Application
      • 12.3.2 Global Medical Radioactive Isotopes Sales Value Forecast by Application
      • 12.3.3 Global Medical Radioactive Isotopes Price Forecast by Application

    13 Global Medical Radioactive Isotopes Market Forecast by Region/Country

    • 13.1 Global Medical Radioactive Isotopes Market Forecast by Region (2023-2028)
      • 13.1.1 Global Medical Radioactive Isotopes Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Medical Radioactive Isotopes Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Rosatom
      • 14.1.1 Company Information
      • 14.1.2 Medical Radioactive Isotopes Product Introduction
      • 14.1.3 Rosatom Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Polatom
      • 14.2.1 Company Information
      • 14.2.2 Medical Radioactive Isotopes Product Introduction
      • 14.2.3 Polatom Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 NTP Radioisotopes
      • 14.3.1 Company Information
      • 14.3.2 Medical Radioactive Isotopes Product Introduction
      • 14.3.3 NTP Radioisotopes Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 NRG
      • 14.4.1 Company Information
      • 14.4.2 Medical Radioactive Isotopes Product Introduction
      • 14.4.3 NRG Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Nordion
      • 14.5.1 Company Information
      • 14.5.2 Medical Radioactive Isotopes Product Introduction
      • 14.5.3 Nordion Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 IRE
      • 14.6.1 Company Information
      • 14.6.2 Medical Radioactive Isotopes Product Introduction
      • 14.6.3 IRE Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Eckert & Ziegler Strahlen
      • 14.7.1 Company Information
      • 14.7.2 Medical Radioactive Isotopes Product Introduction
      • 14.7.3 Eckert & Ziegler Strahlen Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 China National Nuclear Corporation
      • 14.8.1 Company Information
      • 14.8.2 Medical Radioactive Isotopes Product Introduction
      • 14.8.3 China National Nuclear Corporation Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 ANSTO
      • 14.9.1 Company Information
      • 14.9.2 Medical Radioactive Isotopes Product Introduction
      • 14.9.3 ANSTO Medical Radioactive Isotopes Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Medical Radioactive Isotopes market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Medical Radioactive Isotopes industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Medical Radioactive Isotopes market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Medical Radioactive Isotopes Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Medical Radioactive Isotopes market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Medical Radioactive Isotopes Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Medical Radioactive Isotopes industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Tc-99m
      Cobalt-60

      Segmented by Application
      Nuclear Therapy
      Equipment Radioactive Source
      Diagnosis
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      NTP Radioisotopes
      NRG
      Nordion
      IRE
      Eckert & Ziegler Strahlen
      China National Nuclear Corporation
      ANSTO

      Buy now